Skip to main content

Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

Publisher: Bentham Science Publishers

Volume 8, Number 2, May 2012

Articles

Editorial (Metastases Prevention is the Cure)
pp. 79-80(2)
Author: S. Zaenker, Kurt

Favourites:
ADD

Sympathetic Signaling in Angiogenesis: Implications for Cancer Progression
pp. 83-89(7)
Authors: Tilan, Jason; Czarnecka, Magdalena; Kitlinska, Joanna

Favourites:
ADD

Adrenergic Action in Breast Cancer
pp. 90-99(10)
Authors: Alicia Luthy, Isabel; Bruzzone, Ariana; Perez Pinero, Cecilia

Favourites:
ADD

Stress Related Neuroendocrine Influences in Ovarian Cancer
pp. 100-109(10)
Authors: Kang, Yu; K. Lutgendorf, Susan; Hu, Wei; W. Cole, Steven; K. Sood, Anil

Favourites:
ADD

The Adrenergic System in Gastrointestinal Cancers
pp. 110-115(6)
Authors: Jie Li, Zhi; Hin Cho, Chi

Favourites:
ADD

Beta-adrenergic Signaling in the Development and Progression of Pulmonary and Pancreatic Adenocarcinoma
pp. 116-127(12)
Authors: M. Schuller, Hildegard; A. N. Al-Wadei, Hussein

Favourites:
ADD
Favourites:
ADD

BCL-2 Family Proteins: The Mitochondrial Apoptotic Key Regulators
pp. 133-140(8)
Authors: Daisy, P.; Saipriya, K.

Favourites:
ADD

Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer
pp. 141-151(11)
Authors: B. Diamond, Melissa; I. Franco, Vivian; L. Miller, Tracie; E. Lipshultz, Steven

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more